Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Titel:
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Auteur:
Champiat, Stephane Garralda, Elena Galvao, Vladimir Cassier, Philippe A. Gomez-Roca, Carlos Korakis, Iphigenie Grell, Peter Naing, Aung LoRusso, Patricia Mikyskova, Romana Podzimkova, Nada Reinis, Milan Ouali, Kaissa Schoenenberger, Andreu Kiemle-Kallee, Joachim Tillmanns, Sascha Sachse, Richard Moebius, Ulrich Spisek, Radek Bechard, David Jelinkova, Lenka Palova Adkins, Irena Marabelle, Aurelien